Serum marker analysis of UC patients versus non-UC donors.
收藏数据链接：
官方服务：
资源简介：
Sample sizes: UC = 49, non-UC = 23.
应用场景：
创建时间：
2020-02-12
相关数据集
Supplementary Material for: Plasma concentration of calprotectin, but not serum concentration, is a predictive biomarker for clinical remission in ulcerative colitis
Introduction Fecal calprotectin is a validated biomarker for assessing disease activity in patients with inflammatory bowel disease (IBD). Blood calprotectin concentrations are correlated with disease
DataCite Commons2025-04-09 更新50
Tissue cytokines/chemokines profiles.
± SD. Statistical analysis performed as in Table 2. *ppppppan = 34 controls, 26 quiescent UC, and 60 active UC. bn = 20 controls, 19 quiescent UC, and 23 active UC. cn = 34 controls, 26 quiescent UC,
Figshare2015-12-02 更新30
Characterization of disulfidptosis-related genes.
BackgroundUlcerative colitis (UC) is a recurrent inflammatory condition of the bowel with a multifaceted pathogenesis, including programmed cell death, oxidative stress, and immune-mediated inflammati
Figshare2025-06-06 更新30
Serum Glycan Markers for Evaluation of Disease Activity and Prediction of Clinical Course in Patients with Ulcerative Colitis
Background The aims of this study were to determine the change of whole-serum N-glycan profile in ulcerative colitis (UC) patients and to investigate its clinical utility. Methods We collected serum f
NIAID Data Ecosystem50
Differences in ghrelin staining, biochemical parameters and age between control group and ulcerative colitis patients.
Differences in ghrelin staining, biochemical parameters and age between control group and ulcerative colitis patients.
NIAID Data Ecosystem30
